Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1
US7598228B2 · kind B2 · utility
92Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2003 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Nov 16, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/347
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A prophylactic or therapeutic method for a disease associated with decreased expression of AOP-1 gene or AOP-1, comprising (1) transfecting a nucleic acid encoding AOP-1 or a nucleic acid encoding a polypeptide having an addition, deletion or substitution of one or more amino acids as compared with the amino acid sequence of AOP-1 while retaining the function of AOP-1, or (2) administering a material enhancing the expression of AOP-1 gene, a material enhancing the production of AOP-1 or a material enhancing the function of AOP-1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.